Matthew B. Barajas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthew B. Barajas has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Matthias L. Riess
Anesthesiology, TVHS VA Medical Center, Nashville, TN 37212, USA
8 shared publications - Zhu Li
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
7 shared publications - Takuro Oyama
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
5 shared publications - Masakazu Shiota
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
4 shared publications Matthias L. Riess
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, USA
3 shared publicationsFranz J. Baudenbacher
Department of Biomedical Engineering, Vanderbilt University, Nashville, USA
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- p. 1-7
Peripheral intravenous waveform analysis – a novel tool to confirm intravascular catheter placement
Peripheral intravenous (IV) catheter infiltration is a common complication which can cause harmful extravasation of fluid and medications. Significant injury can occur before standard infusion pumps detect a threshold pressure. Peripheral IV waveform analysis (PIVA) uses fast Fourier transform (FFT) to measure the amplitude of the venous waveform. This study aims to evaluate if PIVA can differentiate between IV catheter positions, primarily intravenous versus subcutaneous, in a rat model. Surgical cutdown was performed on the right proximal saphenous vein. Pressure and waveforms were recorded from a 22G IV catheter open-to-air, in the vein, and in the adjacent subcutaneous (SC) tissue. Measurements were performed at baseline and after injection of 1 mL Plasmalyte and are reported as median (interquartile range). The peak amplitude corresponding to the heart rate frequency labeled as f1. Pre-flush intravascular f1, 0.0824 mmHg (IQR 0.0256, 0.1480), differed significantly from both SC, 0.0001 mmHg (0.0000, 0.0004), and open-to-air, 0.0001 mmHg (0.0000, 0.0008), conditions, ANOVA p = 0.03, pairwise p = 0.049 and 0.049, respectively. These significant differences remained after flush. Post-flush pressures between IV, 7.9 mmHg (6.6, 8.9) and SC, 20.5 mmHg (11.3, 28.8) were significantly different, p = 0.0001. There was no significant difference in pre-flush and post-flush pressure within IV, SC, and open-air groups, p = 0.687, p = 0.110 and p = 0.219, respectively. PIVA was superior to absolute pressure measurement for detecting intravascular versus extravascular placement of an IV catheter. This study demonstrates utility of PIVA as a novel method for confirming proper IV placement.
- 29 October 2026
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- p. 1-7
Open AccessPeripheral intravenous waveform analysis – a novel tool to confirm intravascular catheter placement
Peripheral intravenous (IV) catheter infiltration is a common complication which can cause harmful extravasation of fluid and medications. Significant injury can occur before standard infusion pumps detect a threshold pressure. Peripheral IV waveform analysis (PIVA) uses fast Fourier transform (FFT) to measure the amplitude of the venous waveform. This study aims to evaluate if PIVA can differentiate between IV catheter positions, primarily intravenous versus subcutaneous, in a rat model. Surgical cutdown was performed on the right proximal saphenous vein. Pressure and waveforms were recorded from a 22G IV catheter open-to-air, in the vein, and in the adjacent subcutaneous (SC) tissue. Measurements were performed at baseline and after injection of 1 mL Plasmalyte and are reported as median (interquartile range). The peak amplitude corresponding to the heart rate frequency labeled as f1. Pre-flush intravascular f1, 0.0824 mmHg (IQR 0.0256, 0.1480), differed significantly from both SC, 0.0001 mmHg (0.0000, 0.0004), and open-to-air, 0.0001 mmHg (0.0000, 0.0008), conditions, ANOVA p = 0.03, pairwise p = 0.049 and 0.049, respectively. These significant differences remained after flush. Post-flush pressures between IV, 7.9 mmHg (6.6, 8.9) and SC, 20.5 mmHg (11.3, 28.8) were significantly different, p = 0.0001. There was no significant difference in pre-flush and post-flush pressure within IV, SC, and open-air groups, p = 0.687, p = 0.110 and p = 0.219, respectively. PIVA was superior to absolute pressure measurement for detecting intravascular versus extravascular placement of an IV catheter. This study demonstrates utility of PIVA as a novel method for confirming proper IV placement.
- Open Access
- 1 August 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (8) , 78
Diabetes Worsens Outcomes After Asphyxial Cardiac Arrest in Rats
Background: Diabetes mellitus is associated with worse outcomes after cardiac arrest. Hyperglycemia, diabetes treatments and other long-term sequalae may contribute to this association. We sought to determine the acute effect of diabetes on the return of spontaneous circulation (ROSC) and post-arrest cardiac function in a rat cardiac arrest model. Methods: Eighteen male Wistar rats were utilized, and 12 underwent the induction of type II diabetes for 10 weeks through a high-fat diet and the injection of streptozotocin. The carotid artery flow and femoral arterial pressure were measured. Seven minutes of asphyxial cardiac arrest was induced. An external cardiac compression was performed via an automated piston. Post-ROSC, epinephrine was titrated to a mean arterial pressure (MAP) of 70 mmHg. Data was analyzed using the Mann–Whitney test. The significance was set at p ≤ 0.05. Results: The rate of the ROSC was significantly lower in animals with diabetes, 50% compared to 100% in non-diabetics. Additionally, it took significantly longer to achieve the ROSC in diabetics, p = 0.034. In animals who survived, the cardiac function was reduced, as indicated by an increased epinephrine requirement, p = 0.041, and a decreased cardiac output at the end of the experiment, p = 0.017. The lactate, venous and arterial pressures, heart rate and carotid flow did not differ between groups at 2 h. Conclusions: Diabetes negatively affects the survival from cardiac arrest. Here, the critical difference was the rate of the conversion to a life-sustaining rhythm and the achievement of the ROSC. The post-ROSC cardiac function was depressed in diabetic animals. Interventions targeted at improving defibrillation success may be important in diabetics.
- 1 August 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (8) , 78
Open AccessDiabetes Worsens Outcomes After Asphyxial Cardiac Arrest in Rats
Background: Diabetes mellitus is associated with worse outcomes after cardiac arrest. Hyperglycemia, diabetes treatments and other long-term sequalae may contribute to this association. We sought to determine the acute effect of diabetes on the return of spontaneous circulation (ROSC) and post-arrest cardiac function in a rat cardiac arrest model. Methods: Eighteen male Wistar rats were utilized, and 12 underwent the induction of type II diabetes for 10 weeks through a high-fat diet and the injection of streptozotocin. The carotid artery flow and femoral arterial pressure were measured. Seven minutes of asphyxial cardiac arrest was induced. An external cardiac compression was performed via an automated piston. Post-ROSC, epinephrine was titrated to a mean arterial pressure (MAP) of 70 mmHg. Data was analyzed using the Mann–Whitney test. The significance was set at p ≤ 0.05. Results: The rate of the ROSC was significantly lower in animals with diabetes, 50% compared to 100% in non-diabetics. Additionally, it took significantly longer to achieve the ROSC in diabetics, p = 0.034. In animals who survived, the cardiac function was reduced, as indicated by an increased epinephrine requirement, p = 0.041, and a decreased cardiac output at the end of the experiment, p = 0.017. The lactate, venous and arterial pressures, heart rate and carotid flow did not differ between groups at 2 h. Conclusions: Diabetes negatively affects the survival from cardiac arrest. Here, the critical difference was the rate of the conversion to a life-sustaining rhythm and the achievement of the ROSC. The post-ROSC cardiac function was depressed in diabetic animals. Interventions targeted at improving defibrillation success may be important in diabetics.
- Open Access
Role of Nitric Oxide in Cardioprotection by Poloxamer 188
Poloxamer (P) 188 attenuates myocardial ischemia/reperfusion injury through cell membrane stabilization. Cell–cell interactions between endothelial cells (ECs) and cardiomyocytes (CMs) further protect CMs: co-cultures showed that, at an optimal density, ECs protected CMs against hypoxia/reoxygenation (HR) injury. The mechanism of interaction with P188 still requires exploration. We examined if N(ω)-nitro-L-arginine methyl ester (LNAME), a non-specific nitric oxide (NO) synthase inhibitor, abolishes protection in the presence or absence of P188 and/or ECs. We co-cultured mouse coronary artery ECs in an insert atop mouse CMs plated at confluency on the bottom of a well. Normoxic controls remained in complete media while HR groups were exposed to 24 h hypoxia at 0.01% O2 in serum- and glucose-free media, followed by 2 h reoxygenation in complete media. P188 (300 μM), LNAME (40 mM), or vehicle were administered upon reoxygenation. ECs at the used lower density did not decrease HR-triggered lactate dehydrogenase release or calcium overload in CMs by themselves. P188 reduced both indicators after HR by 16/18% without and by 22/25% with ECs, respectively. LNAME abrogated CM protection by P188. Neither intervention had an effect under normoxia. Our co-culture data indicates that P188 requires NO, not necessarily of endothelial origin, to elicit CM protection.
Open AccessRole of Nitric Oxide in Cardioprotection by Poloxamer 188
Poloxamer (P) 188 attenuates myocardial ischemia/reperfusion injury through cell membrane stabilization. Cell–cell interactions between endothelial cells (ECs) and cardiomyocytes (CMs) further protect CMs: co-cultures showed that, at an optimal density, ECs protected CMs against hypoxia/reoxygenation (HR) injury. The mechanism of interaction with P188 still requires exploration. We examined if N(ω)-nitro-L-arginine methyl ester (LNAME), a non-specific nitric oxide (NO) synthase inhibitor, abolishes protection in the presence or absence of P188 and/or ECs. We co-cultured mouse coronary artery ECs in an insert atop mouse CMs plated at confluency on the bottom of a well. Normoxic controls remained in complete media while HR groups were exposed to 24 h hypoxia at 0.01% O2 in serum- and glucose-free media, followed by 2 h reoxygenation in complete media. P188 (300 μM), LNAME (40 mM), or vehicle were administered upon reoxygenation. ECs at the used lower density did not decrease HR-triggered lactate dehydrogenase release or calcium overload in CMs by themselves. P188 reduced both indicators after HR by 16/18% without and by 22/25% with ECs, respectively. LNAME abrogated CM protection by P188. Neither intervention had an effect under normoxia. Our co-culture data indicates that P188 requires NO, not necessarily of endothelial origin, to elicit CM protection.
- Open Access
- 24 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6050
Effects of High Glucose on Simulated Ischemia/Reperfusion Injury in Isolated Cardiomyocytes
The rising prevalence of type 2 diabetes is linked to an increased risk of cardiovascular diseases, with the diabetic heart being particularly vulnerable to ischemia–reperfusion (IR) injury. Chronic hyperglycemia contributes to an increase in reactive oxygen species and impacts the homeostasis of biochemical pathways, including the polyol pathway, increasing susceptibility to damage. Aldose reductase (AR), a key enzyme in this pathway, has been targeted for therapeutic intervention, with AR inhibitors showing potential in mitigating diabetic complications. This study investigated IR injury in cardiomyocytes following high glucose exposure and assessed the AR inhibitor Epalrestat as a protective agent. Cardiomyocyte function was evaluated by measuring lactate dehydrogenase (LDH) release, FM1-43 membrane incorporation, cell viability, intracellular calcium accumulation, and superoxide anion formation. High glucose exposure and simulated IR led to increased LDH release, FM1-43 incorporation, intracellular calcium, and superoxide levels, alongside reduced cell viability in a dose-dependent manner. However, Epalrestat treatment during high glucose exposure significantly reduced IR-induced injury. These findings suggest that high glucose exacerbates IR injury in cardiomyocytes, with the polyol pathway playing a critical role. Targeting this pathway with AR inhibitors like Epalrestat may offer a protective strategy against diabetic heart complications.
- 24 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6050
Open AccessEffects of High Glucose on Simulated Ischemia/Reperfusion Injury in Isolated Cardiomyocytes
The rising prevalence of type 2 diabetes is linked to an increased risk of cardiovascular diseases, with the diabetic heart being particularly vulnerable to ischemia–reperfusion (IR) injury. Chronic hyperglycemia contributes to an increase in reactive oxygen species and impacts the homeostasis of biochemical pathways, including the polyol pathway, increasing susceptibility to damage. Aldose reductase (AR), a key enzyme in this pathway, has been targeted for therapeutic intervention, with AR inhibitors showing potential in mitigating diabetic complications. This study investigated IR injury in cardiomyocytes following high glucose exposure and assessed the AR inhibitor Epalrestat as a protective agent. Cardiomyocyte function was evaluated by measuring lactate dehydrogenase (LDH) release, FM1-43 membrane incorporation, cell viability, intracellular calcium accumulation, and superoxide anion formation. High glucose exposure and simulated IR led to increased LDH release, FM1-43 incorporation, intracellular calcium, and superoxide levels, alongside reduced cell viability in a dose-dependent manner. However, Epalrestat treatment during high glucose exposure significantly reduced IR-induced injury. These findings suggest that high glucose exacerbates IR injury in cardiomyocytes, with the polyol pathway playing a critical role. Targeting this pathway with AR inhibitors like Epalrestat may offer a protective strategy against diabetic heart complications.
- Open Access
Time Variable Models of Severe Hemorrhagic Shock in Rats
Background: Classical teaching dictates that damage control resuscitation is ideally implemented within the first or ‘golden’ hour after trauma-related hemorrhage. Given the heterogeneity of trauma, varied models must be utilized to guide ongoing investigation. We sought to determine exactly what happens during the ‘golden hour’ by varying hemorrhage and down times and mimicking venous or arterial bleeding while varying oxygen therapy, a readily available pre-hospital intervention, on survival in a small-animal rodent model. Methods: Rats were bled by 40% of their blood volume over 30 or 60 min, with varied ‘down-times’ of 30, 45, or 60 min. FiO2 was administered at 21% or 40%, mimicking nasal cannula. Multiple linear regression was performed between the independent variables and each measured outcome. Sub-group analyses were stratified by survival. Results: There was no statistically significant variation in end-organ insult (lactate), cardiac functioning (cardiac output or left ventricle fractional area of change), mean arterial pressure at end experiment, survival, or survival times among the groups. Conclusions: This study adds to the data against an all-encompassing golden hour, as even a rapid hemorrhage with long down time did not decrease survival. Furthermore, we add to the body of literature in this field by examining cardiac markers of injury with transthoracic echocardiography.
Open AccessTime Variable Models of Severe Hemorrhagic Shock in Rats
Background: Classical teaching dictates that damage control resuscitation is ideally implemented within the first or ‘golden’ hour after trauma-related hemorrhage. Given the heterogeneity of trauma, varied models must be utilized to guide ongoing investigation. We sought to determine exactly what happens during the ‘golden hour’ by varying hemorrhage and down times and mimicking venous or arterial bleeding while varying oxygen therapy, a readily available pre-hospital intervention, on survival in a small-animal rodent model. Methods: Rats were bled by 40% of their blood volume over 30 or 60 min, with varied ‘down-times’ of 30, 45, or 60 min. FiO2 was administered at 21% or 40%, mimicking nasal cannula. Multiple linear regression was performed between the independent variables and each measured outcome. Sub-group analyses were stratified by survival. Results: There was no statistically significant variation in end-organ insult (lactate), cardiac functioning (cardiac output or left ventricle fractional area of change), mean arterial pressure at end experiment, survival, or survival times among the groups. Conclusions: This study adds to the data against an all-encompassing golden hour, as even a rapid hemorrhage with long down time did not decrease survival. Furthermore, we add to the body of literature in this field by examining cardiac markers of injury with transthoracic echocardiography.
- Open Access
Ischemic Post-Conditioning in a Rat Model of Asphyxial Cardiac Arrest
Background: Ischemic post-conditioning (IPoC) has been shown to improve outcomes in limited pre-clinical models. As down-time is often unknown, this technique needs to be investigated over a range of scenarios. As this tool limits reperfusion injury, there may be limited benefit or even harm after short arrest and limited ischemia-reperfusion injury. Methods: Eighteen male Wistar rats underwent 7 min of asphyxial arrest. Animals randomized to IPoC received a 20 s pause followed by 20 s of compressions, repeated four times, initiated 40 s into cardiopulmonary resuscitation. If return of spontaneous circulation (ROSC) was achieved, epinephrine was titrated to mean arterial pressure (MAP) of 70 mmHg. Data were analyzed using t-test or Mann–Whitney test. Significance set at p ≤ 0.05. Results: The rate of ROSC was equivalent in both groups, 88%. There was no statistically significant difference in time to ROSC, epinephrine required post ROSC, carotid flow, or peak lactate at any timepoint. There was a significantly elevated MAP with IPoC, 90.7 mmHg (SD 13.9), as compared to standard CPR, 76.7 mmHg (8.5), 2 h after ROSC, p = 0.03. Conclusions: IPoC demonstrated no harm in a model of short arrest using a new arrest etiology for CPR based IPoC intervention in a rat model.
Open AccessIschemic Post-Conditioning in a Rat Model of Asphyxial Cardiac Arrest
Background: Ischemic post-conditioning (IPoC) has been shown to improve outcomes in limited pre-clinical models. As down-time is often unknown, this technique needs to be investigated over a range of scenarios. As this tool limits reperfusion injury, there may be limited benefit or even harm after short arrest and limited ischemia-reperfusion injury. Methods: Eighteen male Wistar rats underwent 7 min of asphyxial arrest. Animals randomized to IPoC received a 20 s pause followed by 20 s of compressions, repeated four times, initiated 40 s into cardiopulmonary resuscitation. If return of spontaneous circulation (ROSC) was achieved, epinephrine was titrated to mean arterial pressure (MAP) of 70 mmHg. Data were analyzed using t-test or Mann–Whitney test. Significance set at p ≤ 0.05. Results: The rate of ROSC was equivalent in both groups, 88%. There was no statistically significant difference in time to ROSC, epinephrine required post ROSC, carotid flow, or peak lactate at any timepoint. There was a significantly elevated MAP with IPoC, 90.7 mmHg (SD 13.9), as compared to standard CPR, 76.7 mmHg (8.5), 2 h after ROSC, p = 0.03. Conclusions: IPoC demonstrated no harm in a model of short arrest using a new arrest etiology for CPR based IPoC intervention in a rat model.
- Open Access
Newly Developed Di-Block Copolymer-Based Cell Membrane Stabilizers Protect Mouse Coronary Artery Endothelial Cells against Hypoxia/Reoxygenation Injury
Reperfusion after ischemia causes additional cellular damage, known as reperfusion injury, for which there is still no effective remedy. Poloxamer (P)188, a tri-block copolymer-based cell membrane stabilizer (CCMS), has been shown to provide protection against hypoxia/reoxygenation (HR) injury in various models by reducing membrane leakage and apoptosis and improving mitochondrial function. Interestingly, substituting one of its hydrophilic poly-ethylene oxide (PEO) blocks with a (t)ert-butyl terminus added to the hydrophobic poly-propylene oxide (PPO) block yields a di-block compound (PEO-PPOt) that interacts better with the cell membrane lipid bi-layer and exhibits greater cellular protection than the gold standard tri-block P188 (PEO75-PPO30-PEO75). For this study, we custom-made three different new di-blocks (PEO113-PPO10t, PEO226-PPO18t and PEO113-PPO20t) to systemically examine the effects of the length of each polymer block on cellular protection in comparison to P188. Cellular protection was assessed by cell viability, lactate dehydrogenase release, and uptake of FM1-43 in mouse artery endothelial cells (ECs) following HR injury. We found that di-block CCMS were able to provide the same or better EC protection than P188. Our study provides the first direct evidence that custom-made di-block CCMS can be superior to P188 in improving EC membrane protection, raising their potential in treating cardiac reperfusion injury.
Open AccessNewly Developed Di-Block Copolymer-Based Cell Membrane Stabilizers Protect Mouse Coronary Artery Endothelial Cells against Hypoxia/Reoxygenation Injury
Reperfusion after ischemia causes additional cellular damage, known as reperfusion injury, for which there is still no effective remedy. Poloxamer (P)188, a tri-block copolymer-based cell membrane stabilizer (CCMS), has been shown to provide protection against hypoxia/reoxygenation (HR) injury in various models by reducing membrane leakage and apoptosis and improving mitochondrial function. Interestingly, substituting one of its hydrophilic poly-ethylene oxide (PEO) blocks with a (t)ert-butyl terminus added to the hydrophobic poly-propylene oxide (PPO) block yields a di-block compound (PEO-PPOt) that interacts better with the cell membrane lipid bi-layer and exhibits greater cellular protection than the gold standard tri-block P188 (PEO75-PPO30-PEO75). For this study, we custom-made three different new di-blocks (PEO113-PPO10t, PEO226-PPO18t and PEO113-PPO20t) to systemically examine the effects of the length of each polymer block on cellular protection in comparison to P188. Cellular protection was assessed by cell viability, lactate dehydrogenase release, and uptake of FM1-43 in mouse artery endothelial cells (ECs) following HR injury. We found that di-block CCMS were able to provide the same or better EC protection than P188. Our study provides the first direct evidence that custom-made di-block CCMS can be superior to P188 in improving EC membrane protection, raising their potential in treating cardiac reperfusion injury.
- 14 April 2023
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 136 (5) , 941-948
Peripheral Intravenous Waveform Analysis Responsiveness to Subclinical Hemorrhage in a Rat Model
BACKGROUND: Early detection and quantification of perioperative hemorrhage remains challenging. Peripheral intravenous waveform analysis (PIVA) is a novel method that uses a standard intravenous catheter to detect interval hemorrhage. We hypothesize that subclinical blood loss of 2% of the estimated blood volume (EBV) in a rat model of hemorrhage is associated with significant changes in PIVA. Secondarily, we will compare PIVA association with volume loss to other static, invasive, and dynamic markers. METHODS: Eleven male Sprague Dawley rats were anesthetized and mechanically ventilated. A total of 20% of the EBV was removed over ten 5 minute-intervals. The peripheral intravenous pressure waveform was continuously transduced via a 22-G angiocatheter in the saphenous vein and analyzed using MATLAB. Mean arterial pressure (MAP) and central venous pressure (CVP) were continuously monitored. Cardiac output (CO), right ventricular diameter (RVd), and left ventricular end-diastolic area (LVEDA) were evaluated via transthoracic echocardiogram using the short axis left ventricular view. Dynamic markers such as pulse pressure variation (PPV) were calculated from the arterial waveform. The primary outcome was change in the first fundamental frequency (F1) of the venous waveform, which was assessed using analysis of variance (ANOVA). Mean F1 at each blood loss interval was compared to the mean at the subsequent interval. Additionally, the strength of the association between blood loss and F1 and each other marker was quantified using the marginal R 2 in a linear mixed-effects model. RESULTS: PIVA derived mean F1 decreased significantly after hemorrhage of only 2% of the EBV, from 0.17 to 0.11 mm Hg, P = .001, 95% confidence interval (CI) of difference in means 0.02 to 0.10, and decreased significantly from the prior hemorrhage interval at 4%, 6%, 8%, 10%, and 12%. Log F1 demonstrated a marginal R 2 value of 0.57 (95% CI 0.40–0.73), followed by PPV 0.41 (0.28–0.56) and CO 0.39 (0.26–0.58). MAP, LVEDA, and systolic pressure variation displayed R 2 values of 0.31, and the remaining predictors had R 2 values ≤0.2. The difference in log F1 R 2 was not significant when compared to PPV 0.16 (95% CI −0.07 to 0.38), CO 0.18 (−0.06 to 0.04), or MAP 0.25 (−0.01 to 0.49) but was significant for the remaining markers. CONCLUSIONS: The mean F1 amplitude of PIVA was significantly associated with subclinical blood loss and most strongly associated with blood volume among the markers considered. This study demonstrates feasibility of a minimally invasive, low-cost method for monitoring perioperative blood loss.
- 14 April 2023
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 136 (5) , 941-948
Peripheral Intravenous Waveform Analysis Responsiveness to Subclinical Hemorrhage in a Rat Model
BACKGROUND: Early detection and quantification of perioperative hemorrhage remains challenging. Peripheral intravenous waveform analysis (PIVA) is a novel method that uses a standard intravenous catheter to detect interval hemorrhage. We hypothesize that subclinical blood loss of 2% of the estimated blood volume (EBV) in a rat model of hemorrhage is associated with significant changes in PIVA. Secondarily, we will compare PIVA association with volume loss to other static, invasive, and dynamic markers. METHODS: Eleven male Sprague Dawley rats were anesthetized and mechanically ventilated. A total of 20% of the EBV was removed over ten 5 minute-intervals. The peripheral intravenous pressure waveform was continuously transduced via a 22-G angiocatheter in the saphenous vein and analyzed using MATLAB. Mean arterial pressure (MAP) and central venous pressure (CVP) were continuously monitored. Cardiac output (CO), right ventricular diameter (RVd), and left ventricular end-diastolic area (LVEDA) were evaluated via transthoracic echocardiogram using the short axis left ventricular view. Dynamic markers such as pulse pressure variation (PPV) were calculated from the arterial waveform. The primary outcome was change in the first fundamental frequency (F1) of the venous waveform, which was assessed using analysis of variance (ANOVA). Mean F1 at each blood loss interval was compared to the mean at the subsequent interval. Additionally, the strength of the association between blood loss and F1 and each other marker was quantified using the marginal R 2 in a linear mixed-effects model. RESULTS: PIVA derived mean F1 decreased significantly after hemorrhage of only 2% of the EBV, from 0.17 to 0.11 mm Hg, P = .001, 95% confidence interval (CI) of difference in means 0.02 to 0.10, and decreased significantly from the prior hemorrhage interval at 4%, 6%, 8%, 10%, and 12%. Log F1 demonstrated a marginal R 2 value of 0.57 (95% CI 0.40–0.73), followed by PPV 0.41 (0.28–0.56) and CO 0.39 (0.26–0.58). MAP, LVEDA, and systolic pressure variation displayed R 2 values of 0.31, and the remaining predictors had R 2 values ≤0.2. The difference in log F1 R 2 was not significant when compared to PPV 0.16 (95% CI −0.07 to 0.38), CO 0.18 (−0.06 to 0.04), or MAP 0.25 (−0.01 to 0.49) but was significant for the remaining markers. CONCLUSIONS: The mean F1 amplitude of PIVA was significantly associated with subclinical blood loss and most strongly associated with blood volume among the markers considered. This study demonstrates feasibility of a minimally invasive, low-cost method for monitoring perioperative blood loss.
- 10 February 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 192,p. e64995
Current and Novel Experimental Methods in Ischemia/Reperfusion Research: From Cutting-Edge Models to Innovative Therapies
ARTICLES DISCUSSED: Liepinsh, E., Kuka, J., Zvejniece, L., Vilskersts, R., Dambrova, M. Rodent heart and brain tissue preparation for digital macro photography after ischemia-reperfusion. Journal of Visualized Experiments. (180), e62942 (2022). Paro, M. R., Mcgonnigle, M., Bulsara, K., Verma, R. A model for encephalomyosynangiosis treatment after middle cerebral artery occlusion-induced stroke in mice. Journal of Visualized Experiments. (184), e63951 (2022). Compton, T. et al. Non-thermal infrared light treatment of ischemia/reperfusion injury and subsequent analysis of macrophage differentiation. Journal of Visualized Experiments. (178), e62908 (2021). Lv, B. et al. Induction of myocardial infarction and myocardial ischemia-reperfusion injury in mice. Journal of Visualized Experiments. (179), e63257 (2022). Barajas, M. B., Levy, R. J. Modified technique for the use of neonatal murine hearts in the Langendorff preparation. Journal of Visualized Experiments. (181), e63349 (2022). Li, Z., Hampton, M. J., Barajas, M. B., Riess, M. L. Development of a cell co-culture model to mimic cardiac ischemia/reperfusion in vitro. Journal of Visualized Experiments. (176), e62913 (2021). Godoy, J. R., Watson, G., Raspante, C., Illanes, O. An effective mouse model of unilateral renal ischemia-reperfusion injury. Journal of Visualized Experiments. (173), e62749 (2021).
- 10 February 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 192,p. e64995
Current and Novel Experimental Methods in Ischemia/Reperfusion Research: From Cutting-Edge Models to Innovative Therapies
ARTICLES DISCUSSED: Liepinsh, E., Kuka, J., Zvejniece, L., Vilskersts, R., Dambrova, M. Rodent heart and brain tissue preparation for digital macro photography after ischemia-reperfusion. Journal of Visualized Experiments. (180), e62942 (2022). Paro, M. R., Mcgonnigle, M., Bulsara, K., Verma, R. A model for encephalomyosynangiosis treatment after middle cerebral artery occlusion-induced stroke in mice. Journal of Visualized Experiments. (184), e63951 (2022). Compton, T. et al. Non-thermal infrared light treatment of ischemia/reperfusion injury and subsequent analysis of macrophage differentiation. Journal of Visualized Experiments. (178), e62908 (2021). Lv, B. et al. Induction of myocardial infarction and myocardial ischemia-reperfusion injury in mice. Journal of Visualized Experiments. (179), e63257 (2022). Barajas, M. B., Levy, R. J. Modified technique for the use of neonatal murine hearts in the Langendorff preparation. Journal of Visualized Experiments. (181), e63349 (2022). Li, Z., Hampton, M. J., Barajas, M. B., Riess, M. L. Development of a cell co-culture model to mimic cardiac ischemia/reperfusion in vitro. Journal of Visualized Experiments. (176), e62913 (2021). Godoy, J. R., Watson, G., Raspante, C., Illanes, O. An effective mouse model of unilateral renal ischemia-reperfusion injury. Journal of Visualized Experiments. (173), e62749 (2021).
- Open Access
- 7 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 3334
P188 Therapy in In Vitro Models of Traumatic Brain Injury
Traumatic brain injury (TBI) is a significant cause of morbidity and mortality worldwide. Varied mechanisms of injury contribute to the heterogeneity of this patient population as demonstrated by the multiple published grading scales and diverse required criteria leading to diagnoses from mild to severe. TBI pathophysiology is classically separated into a primary injury that is characterized by local tissue destruction as a result of the initial blow, followed by a secondary phase of injury constituted by a score of incompletely understood cellular processes including reperfusion injury, disruption to the blood-brain barrier, excitotoxicity, and metabolic dysregulation. There are currently no effective pharmacological treatments in the wide-spread use for TBI, in large part due to challenges associated with the development of clinically representative in vitro and in vivo models. Poloxamer 188 (P188), a Food and Drug Administration-approved amphiphilic triblock copolymer embeds itself into the plasma membrane of damaged cells. P188 has been shown to have neuroprotective properties on various cell types. The objective of this review is to provide a summary of the current literature on in vitro models of TBI treated with P188.
- 7 February 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 3334
Open AccessP188 Therapy in In Vitro Models of Traumatic Brain Injury
Traumatic brain injury (TBI) is a significant cause of morbidity and mortality worldwide. Varied mechanisms of injury contribute to the heterogeneity of this patient population as demonstrated by the multiple published grading scales and diverse required criteria leading to diagnoses from mild to severe. TBI pathophysiology is classically separated into a primary injury that is characterized by local tissue destruction as a result of the initial blow, followed by a secondary phase of injury constituted by a score of incompletely understood cellular processes including reperfusion injury, disruption to the blood-brain barrier, excitotoxicity, and metabolic dysregulation. There are currently no effective pharmacological treatments in the wide-spread use for TBI, in large part due to challenges associated with the development of clinically representative in vitro and in vivo models. Poloxamer 188 (P188), a Food and Drug Administration-approved amphiphilic triblock copolymer embeds itself into the plasma membrane of damaged cells. P188 has been shown to have neuroprotective properties on various cell types. The objective of this review is to provide a summary of the current literature on in vitro models of TBI treated with P188.